{"organizations": [], "uuid": "b0e39cf072536b031e59a3f19bb407d548d01464", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-avenue-says-dosed-first-patient-in/brief-avenue-says-dosed-first-patient-in-phase-3-safety-trial-of-iv-tramadol-idUSASB0BZF5", "country": "US", "domain_rank": 408, "title": "BRIEF-Avenue Says Dosed First Patient in Phase 3 Safety Trial of IV Tramadol", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-02T15:18:00.000+02:00", "replies_count": 0, "uuid": "b0e39cf072536b031e59a3f19bb407d548d01464"}, "author": "", "url": "https://www.reuters.com/article/brief-avenue-says-dosed-first-patient-in/brief-avenue-says-dosed-first-patient-in-phase-3-safety-trial-of-iv-tramadol-idUSASB0BZF5", "ord_in_thread": 0, "title": "BRIEF-Avenue Says Dosed First Patient in Phase 3 Safety Trial of IV Tramadol", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "afety trial of iv tramadol reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 2, 2018 / 1:19 PM / Updated 9 minutes ago BRIEF-Avenue Says Dosed First Patient in Phase 3 Safety Trial of IV Tramadol Reuters Staff 1 Min Read \nJan 2 (Reuters) - Avenue Therapeutics Inc: \n* AVENUE THERAPEUTICS ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 3 SAFETY TRIAL OF INTRAVENOUS TRAMADOL FOR THE MANAGEMENT OF POSTOPERATIVE PAIN \n* AVENUE THERAPEUTICS INC - COMPANY EXPECTS TO INITIATE A SECOND PHASE 3 TRIAL IN PATIENTS FOLLOWING ABDOMINOPLASTY SURGERY IN Q3 OF 2018 \n* AVENUE THERAPEUTICS- EVALUATING IV TRAMADOL IN PHASE 3 TRIAL IN PATIENTS FOLLOWING BUNIONECTOMY SURGERY, EXPECTS TO REPORT TOPLINE DATA IN Q2,2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-02T15:18:00.000+02:00", "crawled": "2018-01-02T15:36:20.076+02:00", "highlightTitle": ""}